AI-driven platform for early cancer detection and clinical decision support.
Category: Specialized. Pricing: priced per the vendor's website. Last modified: 2026-09-11.
C the Signs is an AI-powered clinical decision support system designed to assist healthcare providers in identifying patients at risk for cancer. By leveraging thousands of validated data points, the platform enables clinicians to make informed referral decisions in under 60 seconds. It aims to improve early diagnosis rates and promote equitable health outcomes within primary care settings.
Not editorially tested: One AI Guide has not published a complete hands-on test record for this tool.
Published by LUMIVEX for One AI Guide.
Editorial lead: Said El Moussaoui. Our methodology is published at /how-we-rate.
Official vendor website: see the vendor link below.
C the Signs is a specialized tool. AI-driven platform for early cancer detection and clinical decision support.
The One AI Guide catalog currently records C the Signs as priced per the vendor's website. This is a directory summary, not a current vendor quote; always check the vendor's site for the latest plans before signing up.
The catalog does not currently record C the Signs as Free or Freemium. That is not proof that no trial or limited offer exists; check the vendor's site for current options.
Common use cases include Early cancer risk assessment, Clinical referral pathway optimization, and Improving health equity in cancer screening.
The One AI Guide catalog currently highlights these strengths: High clinical sensitivity in identifying cancer risk; Reduces time to diagnosis with sub-minute processing; Validated by extensive peer-reviewed clinical research.